HealthcareServices

Global Metagenomics In Healthcare Industry Trends: Where the Market Is Headed by 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Metagenomics In Healthcare Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The metagenomics in healthcare market has experienced rapid expansion in recent years. It is anticipated to grow from $2.07 billion in 2024 to $2.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.9%. This historical growth can be attributed to several factors, including the increasing adoption of bioinformatics tools for analyzing complex metagenomic data, the escalating need for rapid and accurate pathogen detection methods, and the growing application of metagenomics in drug discovery and biomarker identification.

The metagenomics in healthcare market is set to experience substantial growth in the coming years, with its size projected to reach $4.66 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 17.6%. This anticipated expansion is driven by factors such as the rising prevalence of infectious diseases, an increasing demand for precision medicine, a heightened focus on antimicrobial resistance surveillance utilizing metagenomics, the expanding applications of metagenomics in oncology research and diagnostics, and growing awareness regarding microbiome-based therapies and interventions. Key trends in this period are expected to include technological advancements in sequencing platforms, innovations within bioinformatics pipelines, developments in single-cell metagenomics, ongoing research and development in microbiome therapeutics, and the integration of artificial intelligence into data analysis.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp

What Are The Key Drivers Of Growth In The Metagenomics In Healthcare Market?

The rising incidence of infectious diseases is projected to stimulate expansion within the metagenomics in healthcare market. These ailments are characterized by their origin in detrimental microorganisms—such as bacteria, viruses, fungi, or parasites—and their capacity to transmit between individuals. A key factor contributing to this growing prevalence is increased global travel, which accelerates the cross-border dissemination of pathogens. Within healthcare, metagenomics aids in confronting infectious diseases through its ability to quickly and accurately identify pathogens, which is vital for managing disease outbreaks. It also diminishes diagnostic ambiguity by scrutinizing intricate microbial communities, thus enhancing patient recovery and informing specific treatment approaches. As an illustration, the UK Health Security Agency reported in February 2024 that cases of tuberculosis—a contagious bacterial infection predominantly affecting the lungs—in England increased to 4,850 in 2023, marking a 10.7% rise from 4,380 cases in 2022. Consequently, the expanding prevalence of infectious diseases acts as a primary catalyst for the growth of the metagenomics in healthcare market.

What Are The Key Segments In The Metagenomics In Healthcare Market?

The metagenomics in healthcare market covered in this report is segmented as

1) By Types: Sample Extraction Kits, Metagenomics Kits

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray

3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing

4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits

2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

How Are Emerging Market Trends Shaping The Metagenomics In Healthcare Industry Landscape?

Leading companies operating in the metagenomics in healthcare market are focusing on developing innovative solutions, such as microbial community profiling, to improve disease diagnostics, enable personalized therapies, and advance precision medicine. Microbial community profiling refers to the comprehensive analysis and characterization of diverse microbial populations within a specific environment or sample, utilizing sequencing and bioinformatics tools to identify their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched a Human Microbiome Metagenomics Sequencing Package to advance microbial research and healthcare applications. This package provides an automated, end-to-end microbial community profiling workflow for efficiently analyzing human microbiome diversity, function, and disease links using validated high-throughput platforms. It minimizes manual labor, enhances reproducibility, and reduces costs, thereby making large-scale and clinical microbiome research more accessible. Researchers benefit from fast and precise microbial identification, along with adaptable throughput, facilitating biomarker discovery and advancing translational health research.

Who Are The Major Companies Operating In The Metagenomics In Healthcare Market?

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Metagenomics In Healthcare Market?

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Metagenomics In Healthcare Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28267&type=smp

Browse Through More Reports Similar to the Global Metagenomics In Healthcare Market 2025, By The Business Research Company

Metagenomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Metagenomic Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795